1489 West Warm Springs Road
Suite 110
Henderson, NV 89014
United States
646 650 1351
https://www.volition.com
Sector(es): Healthcare
Industria: Diagnostics & Research
Empleados a tiempo completo: 110
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Dr. Martin Charles Faulkes Ph.D. | Executive Chairman | 227.63k | N/D | 1944 |
Mr. Cameron Reynolds MBA | Founder, CEO, President & Director | 538.66k | N/D | 1971 |
Dr. Jacob Vincent Micallef MBA, Ph.D. | Chief Scientific Officer | 571.55k | N/D | 1956 |
Mr. Nicholas Plummer | Group General Counsel | N/D | N/D | 1971 |
Mr. Gael Forterre M.B.A. | Chief Commercial Officer | N/D | N/D | 1982 |
Ms. Sharon Ballesteros | U.S. Head of Quality & Development Process | N/D | N/D | N/D |
Mr. Rodney Gerard Rootsaert LLB | Corporate Secretary | 126.23k | N/D | 1971 |
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening blood test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.
La calificación ISS Governance QuickScore de VolitionRx Limited a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.